# Effect of Supplemental Intake of Omega-3 Polyunsaturated Fatty Acids on the Rate and Complexity of Spontaneously Occurring Ventricular and Supraventricular Arrhythmias in Patients With Implantable Cardioverter Defibrillator (ICD) - A Randomized Clinical Trial

> **NCT00290056** · PHASE4 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 105 (actual)

## Conditions studied

- Coronary Artery Disease
- Arrhythmia

## Interventions

- **DRUG:** Eicosapentanoic acid (EPA) and Docosahexanoic acid (DHA).

## Key facts

- **NCT ID:** NCT00290056
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-11
- **Primary completion:** 2009-11
- **Final completion:** 2010-06
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2009-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00290056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00290056, "Effect of Supplemental Intake of Omega-3 Polyunsaturated Fatty Acids on the Rate and Complexity of Spontaneously Occurring Ventricular and Supraventricular Arrhythmias in Patients With Implantable Cardioverter Defibrillator (ICD) - A Randomized Clinical Trial". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00290056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*